Multiple myeloma and the translocation t(11;14)(q13;q32): A report on 13 cases

British Journal of Haematology

Volumn 101, Issue 2, 1998, Pages 296-301

  Fonseca, Rafael ^a   Witzig, Thomas E ^a   Gertz, Morie A ^a   Kyle, Robert A ^a   Hoyer, James D ^a   Jalal, Syed M ^a   Greipp, Philip R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chromosomal aberrations; Cyclins; Multiple myeloma; Plasmacytic leukaemia; Translocation (genetics)

Indexed keywords

BETA 2 MICROGLOBULIN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME 13Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MALE; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; HEMOGLOBINS; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLATELET COUNT; RECURRENCE; TRANSLOCATION, GENETIC;

EID: 0031838436     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00700.x     Document Type: Article

References (50)

1. Bergsagel, P.L., Chesi, M., Nardini, E., Brents, L.A., Kirby, S.L. & Kuehl, W.M. (1996) Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America, 93, 13931-13936.
2. Billadeau, D., Van Ness, B., Kimlinger, T., Kyle, R.A., Therneau, T.M., Greipp, P.R. & Witzig, T.E. (1996) Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood, 88, 289-296.
3. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., Tassies, D., Jaffe, E.S., Montserrat, E., Rozman, C. & Cardesa, A. (1994) PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood, 84, 2726-2732.
4. Chen, K.-C., Bevan, P.C. & Matthews, J.G. (1986) Analysis of G handed karyotypes in myeloma cells. Journal of Clinical Pathology, 39, 260-266.
5. Chesi, M., Bergsagel, P.L., Brents, L.A., Smith, C.M., Gerhard, D.S. & Kuehl, W.M. (1996) Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood, 88, 674-681.
6. de Boer, C.J., Loyson, S., Kluin, P.M., Kluin-Nelemans, H.C., Schuuring, E. & van Krieken, J.H. (1993) Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Research, 53, 4148-4152.
7. de Boer, C.J., van Krieken, J.H., Kluin-Nelemans, H.C., Kluin, P.M. & Schuuring, E. (1995) Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene, 10, 1833-1840.
8. Dewald, G.W., Kyle, R.A., Hicks, G.A. & Greipp, P.R. (1995) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood, 66, 380-390.
9. Drach, J., Angerler, J., Schuster, J., Nowotny, H., Scherrer, R., Jäger, U., Heinz, R., Geissler, K., Lechner, K., Ludwig, H. & Huber, H. (1994) Interphase cytogenic studies in multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS). (Abstract). Blood, 84, (Suppl. 1), 173A.
10. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842-854.
11. Facon, T., Flactif, M., Zandecki, M., Bernardi, F., Bauters, F. & Laï, J.L. (1994) Fluorescence in situ hybridization improves the detection of cytogenetic abnormalities in multiple myeloma. (Abstract). Blood, 84, (Suppl.) 523A.
12. Fiedler, W., Weh, H.J. & Hossfeld, D.K. (1992) Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma. British Journal of Haematology, 81, 58-61.
13. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. & Dalla-Favera, R. (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 88, 5413-5417.
14. Greil, R., Fasching, B. & Huber, H. (1989) In situ hybridization for the detection of low copy numbers of c-abl oncogene mRNA in lymphoma cells: technical approach and comparison with results with anti-oncoprotein antibodies. Laboratory Investigation, 60, 574-582.
15. Greipp, P.R. & Kyle, R.A. (1983) Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood, 62, 166-171.
16. Greipp, P.R., Lust, J.A., O'Fallon, W.M., Katzmann, J.A., Witzig, T.E. & Kyle, R.A. (1993) Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood, 82, 3382-3387.
17. Kobayashi, H., Saito, H., Kitano, K., Kiyosawa, K., Gaun, S., Aoki, K., Narita, A., Watanabe, M., Uchimaru, K. & Motokura, T. (1995) Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32). Acta Haematologia, 94, 199-203.
18. Kyle, R.A. (1975) Multiple myeloma: review of 869 cases. Mayo Clinic Proceedings, 50, 29-40.
19. Laï, J.L., Mary, J.Y., Zandecki, M., Flactif, M., Bernardi, F., Izydorczyk, V., Bisiau, H. & Facon, T. (1994) Cytogenetics in multiple myeloma: a study of 176 patients including 133 at diagnosis. (Abstract). Blood, 84, (Suppl.), 523A.
20. Laï, J.L., Michaux, L., Dastugue, N., Daudignon, A., Vasseur, F., Zandecki, M., Bauters, F. & Facon, T. (1996) Cytogenetics in multiple myeloma: a multicentre study of 24 patients with t(11;14)(q13;q32) or variant. (Abstract). Blood, 88, (Suppl. 1), 388a.
21. Laï, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J.P., Bauters, F. & Facon, T. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85, 2490-2497.
22. Leroux, D., Le Marc'Hadour, F., Gressin, R., Jacob, M.C., Keddari, E., Monteil, M., Caillot, P., Jalbert, P. & Sotto, J.J. (1991) Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? British Journal of Haematology, 77, 346-353.
23. Louie, D.C., Traina, T.A., Parsa, N., Linkov, I. & Chaganti, R.S.K. (1996) Immunohistochemical detection of cyclin D1 overexpression in multiple myeloma and plasmacytoid lymphomas with t(11;14)(q13;q32). (Abstract). Blood, 416, (Suppl. 1), 107a.
24. Meeus, P., Stul, M.S., Mecucci, C., Cassiman, J.J. & Van Den Berghe, H. (1995) Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma. Cancer Genetics and Cytogenetics, 83, 25-27.
25. Neri, A., Baldini, L., Trecca, D., Cro, L., Polli, E. & Maiolo, A.T. (1993) p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood, 81, 128-135.
26. Neri, A., Murphy, J.P., Cro, L., Ferrero, D., Tarella, C., Baldini, L. & Dalla-Favera, R. (1989) Ras oncogene mutation in multiple myeloma. Journal of Experimental Medicine, 170, 1715-1725.
27. Nishida, K., Tamura, A., Nakazawa, N., Ueda, Y., Abe, T., Matsuda, F., Kashima, K. & Taniwaki, M. (1997) The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood, 90, 526-534.
28. Nobuyoshi, M., Kawano, M., Tanaka, H., Ishikawa, H., Tanabe, O., Iwato, K., Asaoku, H., Sakai, A. & Kuramoto, A. (1991) Increased expression of the c-myc gene may be related to the aggressive transformation of human cells. British Journal of Haematology, 77, 523-528.
29. Parker, S.L., Tong, T., Bolden, S. & Wingo, P.A. (1996) Cancer statistics, 1996. A Cancer Journal for Clinicians, 46, 5-27.
30. Preudhomme, C., Facon, T., Zandecki, M., Vanrumbeke, M., Laï, J.L., Nataf, E., Loucheux-Lefebvre, M.H., Kerckaert, J.P. & Fenaux, P. (1992) Rare occurrence of P53 gene mutations in multiple myeloma. British Journal of Haematology, 81, 440-443.
31. Raynaud, S.D., Bekri, S., Leroux, D., Grosgeorge, J., Klein, B., Bastard, C., Gaudray, P. & Simon, M.P. (1993) Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes, Chromosomes and Cancer, 8, 80-87.
32. Rimokh, R., Berger, F., Delsol, G., Digonnet, I., Rouault, J.P., Tigaud, J.D., Gadoux, M., Coiffier, B., Bryon, P.A. & Magaud, J.P. (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood, 83, 1871-1875.
33. Sawyer, J.R., Waldron, J.A., Jagannath, S. & Barlogie, B. (1995) Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genetics and Cytogenetics, 82, 41-49.
34. Selvanayagam, P., Blick, M., Narni, F., van Tuinen, P., Ledbetter, D.H., Alexanian, R., Saunders, G.F. & Barlogie, B. (1988) Alteration and abnormal expression of the c-myc oncogene in human myeloma. Blood, 71, 30-35.
35. Seto, M., Yamamoto, K., Iida, S., Akao, Y., Utsumi, K.R., Kubonishi, I., Miyoshi, I., Ohtsuki, T., Yawata, Y., Namba, M., Motokura, T., Arnold, A., Takahashi, T. & Ueda, R. (1992) Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncngene, 7, 1401-1406.
36. Swerdlow, S.H., Yang, W.-I., Zukerberg, L.R., Harris, N.L., Arnold, A. & Williams, M.E. (1995) Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Human Pathology, 26, 999-1004.
37. Taniwaki, M., Nishida, K., Takashima, T., Nakagawa, H., Fujii, H., Tamaki, T., Shimazaki, C., Horiike, S., Misawa, S., Abe, T. & Kashima, K. (1994) Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of lp in 21 patients with multiple myeloma and plasma cell leukemia. Blood, 84, 2283-2290.
38. Tricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D.H., Naucke, S. & Sawyer, J.R. (1995) Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood, 86, 4250-4256.
39. Tricot, G., Sawyer, J.R., Jagannath, S., Desikan, K.R., Siegel, D., Naucke, S., Mattox, S., Bracy, D., Munshi, N. & Barlogie, B. (1997) Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants. Journal of Clinical Oncology, 15, 2659-2666.
40. Tsujimoto, Y., Jaffe, E., Cossman, J., Gorham, J., Nowell, P.C. & Croce, C.M. (1985) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature, 315, 340-343.
41. Vaandrager, J.W., Kluin, P. & Schuuring, E. (1997) The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330kb centromeric from the cyclin D1 gene. (Letter). Blood, 89, 349-350.
42. Vaandrager, J.W., Schuuring, E., Zwikstra, E., de Boer, C.J., Kleiverda, K.K., van Krieken, J.H., Kluin-Nelemans, H.C., van Ommen, G.J., Raap, A.K. & Kluin, P.M. (1996) Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood, 88, 1177-1182.
43. Vandenberghe, E., De Wolf-Peeters, C., van den Oord, J., Wlodarska, I., Delabie, J., Stul, M., Thomas, J., Michaux, J.L., Mecucci, C., Cassiman, J.J. & Van Den Berghe, H. (1991) Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. Journal of Pathology 163, 13-18.
44. Weh, H.J., Gutensohn, K., Selbach, J., Kruse, R., Wacker-Backhaus, G., Seeger, D., Fiedler, W., Fett, W. & Hossfeld, D.K. (1993) Karyotype in multiple myeloma and plasma cell leukaemia. European Journal of Cancer, 29A, 1269-1275.
45. Williams, M.E., Nichols, G.E., Swerdlow, S.H. & Stoler, M.H. (1995) In situ hybridization detection of cyclin D1 mRNA in centrocytic/ mantle cell lymphoma. Annals of Oncology, 6, 297-299.
46. Williams, M.E., Swerdlow, S.H., Rosenberg, C.L. & Arnold, A. (1992) Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Research, Suppl 52, 5541-5545.
47. Williams, M.E., Swerdlow, S.H., Rosenberg, C.L. & Arnold, A. (1993) Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia, 7, 241-245.
48. Witzig, T.E., Gertz, M.A., Lust, J.A., Kyle, R.A., O'Fallon, W.M. & Greipp, P.R. (1996) Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood, 88, 1780-1787.
49. Witzig, T.E., Kyle, R.A., O'Fallon, W.M. & Greipp, P.R. (1994) Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. British Journal of Haematology, 87, 266-272.
50. Zuckerberg, L.R., Yang, W.-I., Arnold, A. & Harris, N.L. (1995) Cyclin D1 expression in non-Hodgkin's lymphomas: detection by immunohistochemistry. American Journal of Clinical Pathology, 103, 756-760.